{"brief_title": "Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis", "brief_summary": "This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.", "condition": ["Atopic Dermatitis"], "criteria": "Inclusion Criteria: - Consenting patients who participated in the core clinical trial", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Safety, atopic dermatitis, adverse event, SAE, extension", "mesh_term": ["Dermatitis", "Dermatitis, Atopic", "Eczema", "Pimecrolimus"], "id": "NCT00098150"}